Question 1

What are the potential benefits of combining Sipuleucel-T with new hormonal agents for my treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer clinical trial (NCT05751941). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer clinical trial (NCT05751941). Contact the study team or your healthcare provider for specific answers.

Question 3

What side effects should I expect from the treatments in this study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer clinical trial (NCT05751941). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there other treatment options available for my condition?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer clinical trial (NCT05751941). Contact the study team or your healthcare provider for specific answers.

Question 5

How often will I need to visit the clinic for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer clinical trial (NCT05751941). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I experience side effects or complications during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study of Sipuleucel-T With or Without Continuing New Hormonal Agents in Metastatic Prostate Cancer clinical trial (NCT05751941). Contact the study team or your healthcare provider for specific answers.

What this study is about